与甲状腺癌和肝细胞癌的伦瓦提尼布坚持相关的因素
Yoshikazu Tateai1, Kazuyoshi Kawakami1, Minori Teramae2
1Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
在日本患有甲状腺癌和肝癌的患者中,伦瓦提尼布的坚持率超过了90%. 不坚持的关键因素包括高血压,出血事件和皮肤反应.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 伦瓦提尼布是治疗甲状腺癌和肝癌的口服抗癌药物.
- 患者的坚持是治疗疗效的关键.
- 这项研究调查了伦瓦提尼布的坚持性和相关因素.
研究的目的:
- 评估在患有特定癌症的患者中伦瓦提尼布的坚持性.
- 为了确定导致伦瓦提尼布粘附性降低的因素.
主要方法:
- 对102名患有甲状腺或肝癌的患者进行了回顾性研究.
- 通过药丸计数和28天周期的自我报告来衡量坚持.
- 采访是为了确定不加入的原因而进行的.
主要成果:
- 林瓦提尼布的中位依附率为甲状腺癌的90.1%,肝癌的94.9%.
- 在甲状腺癌中,出血事件和手脚皮肤反应是主要的不粘附原因.
- 在肝癌中,高血压,声和腹是不坚持的主要因素.
结论:
- 在现实实践中,日本患者的伦瓦提尼布坚持超过了90%.
- 高血压,手脚皮肤反应和腹显著影响了坚持.
- 了解这些因素可以优化林瓦提尼布治疗策略.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Factors Influencing Drug Absorption: Physicochemical Parameters
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
